Credit Suisse Ag Xencor Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Xencor Inc stock. As of the latest transaction made, Credit Suisse Ag holds 93,174 shares of XNCR stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,174

Previous 96,110 3.05%

Holding current value

$2.22 Million

Previous $2.04 Million 1.03%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$18.65 - $26.52 $54,756 - $77,862	-2,936 Reduced 3.05%	93,174 $2.06 Million
Q4 2023 Feb 08, 2024	BUY	$16.53 - $21.42 $168,424 - $218,248	10,189 Added 11.86%	96,110 $2.04 Million
Q3 2023 Nov 13, 2023	SELL	$20.08 - $25.39 $182,426 - $230,668	-9,085 Reduced 9.56%	85,921 $1.73 Million
Q2 2023 Aug 11, 2023	BUY	$24.77 - $29.9 $586,553 - $708,032	23,680 Added 33.2%	95,006 $2.37 Million
Q1 2023 May 10, 2023	BUY	$25.95 - $36.95 $115,581 - $164,575	4,454 Added 6.66%	71,326 $1.99 Million
Q4 2022 Feb 13, 2023	BUY	$24.79 - $30.86 $44,175 - $54,992	1,782 Added 2.74%	66,872 $1.74 Million
Q3 2022 Nov 10, 2022	BUY	$24.62 - $32.44 $60,072 - $79,153	2,440 Added 3.89%	65,090 $1.69 Million
Q2 2022 Aug 12, 2022	SELL	$19.74 - $29.01 $34,860 - $51,231	-1,766 Reduced 2.74%	62,650 $1.72 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $207,437 - $323,673	7,775 Added 13.73%	64,416 $1.72 Million
Q4 2021 Feb 14, 2022	SELL	$33.67 - $43.44 $125,488 - $161,900	-3,727 Reduced 6.17%	56,641 $2.27 Million
Q3 2021 Nov 12, 2021	SELL	$30.65 - $35.68 $254,057 - $295,751	-8,289 Reduced 12.07%	60,368 $1.97 Million
Q2 2021 Aug 16, 2021	SELL	$34.33 - $44.68 $217,411 - $282,958	-6,333 Reduced 8.45%	68,657 $2.37 Million
Q1 2021 May 14, 2021	SELL	$40.81 - $53.88 $880,924 - $1.16 Million	-21,586 Reduced 22.35%	74,990 $3.23 Million
Q4 2020 Feb 12, 2021	BUY	$36.63 - $47.63 $1.1 Million - $1.43 Million	30,037 Added 45.14%	96,576 $4.21 Million
Q3 2020 Nov 13, 2020	SELL	$30.09 - $43.02 $956,230 - $1.37 Million	-31,779 Reduced 32.32%	66,539 $2.58 Million
Q2 2020 Aug 12, 2020	BUY	$27.76 - $33.42 $1.55 Million - $1.87 Million	55,831 Added 131.41%	98,318 $3.18 Million
Q1 2020 May 13, 2020	SELL	$20.69 - $37.79 $108,953 - $199,002	-5,266 Reduced 11.03%	42,487 $1.27 Million
Q4 2019 Feb 12, 2020	BUY	$32.75 - $41.43 $126,087 - $159,505	3,850 Added 8.77%	47,753 $1.64 Million
Q3 2019 Nov 12, 2019	SELL	$33.73 - $46.27 $119,471 - $163,888	-3,542 Reduced 7.47%	43,903 $1.48 Million
Q2 2019 Aug 14, 2019	BUY	$29.6 - $40.93 $6,956 - $9,618	235 Added 0.5%	47,445 $1.94 Million
Q1 2019 May 14, 2019	BUY	$27.85 - $38.09 $8,828 - $12,074	317 Added 0.68%	47,210 $1.47 Million
Q4 2018 Feb 13, 2019	SELL	$32.39 - $42.05 $117,770 - $152,893	-3,636 Reduced 7.2%	46,893 $1.7 Million
Q3 2018 Nov 13, 2018	SELL	$35.69 - $47.65 $282,450 - $377,102	-7,914 Reduced 13.54%	50,529 $1.97 Million
Q2 2018 Aug 14, 2018	BUY	$28.41 - $42.41 $54,433 - $81,257	1,916 Added 3.39%	58,443 $2.16 Million
Q1 2018 May 15, 2018	BUY	$21.18 - $33.78 $220,102 - $351,041	10,392 Added 22.53%	56,527 $1.7 Million
Q4 2017 Feb 14, 2018	SELL	$19.29 - $24.83 $25,597 - $32,949	-1,327 Reduced 2.8%	46,135 $1.01 Million
Q3 2017 Nov 14, 2017	BUY	$19.61 - $23.35 $284,697 - $338,995	14,518 Added 44.07%	47,462 $1.09 Million
Q2 2017 Aug 14, 2017	BUY	N/A	32,944	32,944 $696,000

Others Institutions Holding XNCR

# of Institutions

215

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.42B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account